[go: up one dir, main page]

PE39599A1 - Dispositivo de inhalacion - Google Patents

Dispositivo de inhalacion

Info

Publication number
PE39599A1
PE39599A1 PE1998000011A PE00001198A PE39599A1 PE 39599 A1 PE39599 A1 PE 39599A1 PE 1998000011 A PE1998000011 A PE 1998000011A PE 00001198 A PE00001198 A PE 00001198A PE 39599 A1 PE39599 A1 PE 39599A1
Authority
PE
Peru
Prior art keywords
dosage
dose
deposit
user
communicated
Prior art date
Application number
PE1998000011A
Other languages
English (en)
Inventor
Peter John Brand
Etienne Seguelas
Bosko Dmitrovic
David Buday-Goldberger
Paul Kenneth Rand
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE39599A1 publication Critical patent/PE39599A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Closures For Containers (AREA)
  • Medicinal Preparation (AREA)
  • Catching Or Destruction (AREA)
  • Manipulator (AREA)

Abstract

QUE COMPRENDE: A) UN CUERPO QUE DEFINE UN DEPOSITO PARA MEDICAMENTO EN LA FORMA DE UN POLVO; B) UNA SALIDA A TRAVES DE LA CUAL UN USUARIO PUEDE INHALAR; Y C) UN MIEMBRO DE DOSIFICACION, CON AL MENOS UN REBAJO DE DOSIFICACION FORMADO EN EL MISMO, QUE ES MOVIBLE ENTRE UNA PRIMERA POSICION EN LA CUAL AL MENOS UN REBAJO DE DOSIFICACION SE COMUNICA CON EL DEPOSITO PARA RECIBIR UNA DOSIS DE POLVO DESDE EL MISMO, Y UNA SEGUNDA POSICION EN LA CUAL AL MENOS UN REBAJO DE DOSIFICACION SE COMUNICA CON LA SALIDA PARA PERMITIR AL USUARIO INHALAR LA DOSIS, ADEMAS AL MENOS UN REBAJO DE DOSIFICACION ESTA FORMADO EN UNA CARA O SUPERFICIE DEL MIEMBRO DE DOSIFICACION QUE SE PRESIONA PARA PONERSE EN CONTACTO CONTRA UNA SUPERFICIE O CARA DE ACOPLAMIENTO SIMILAR DEL CUERPO EN EL EXTREMO INFERIOR DEL DEPOSITO PARA FORMAR UN SELLO DINAMICO, CARACTERIZADO EN QUE AL MENOS UNA DE DICHAS CARAS O SUPERFICIES SE HACE DE UN MATERIAL FLEXIBLE QUE TIENE UNA DUREZA DE MENOS DE 80 SHORE A Y UN COEFICIENTE DE FRICCION DE 0,4 O MENOS. DICHO DISPOSITIVO SE USA PARA DISPERSAR DOSIS MEDIDAS DE MEDICAMENTO EN LA FORMA DE POLVO A UN USUARIO
PE1998000011A 1997-01-08 1998-01-06 Dispositivo de inhalacion PE39599A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700226.5A GB9700226D0 (en) 1997-01-08 1997-01-08 Inhalation device

Publications (1)

Publication Number Publication Date
PE39599A1 true PE39599A1 (es) 1999-05-05

Family

ID=10805635

Family Applications (2)

Application Number Title Priority Date Filing Date
PE1998000011A PE39599A1 (es) 1997-01-08 1998-01-06 Dispositivo de inhalacion
PE2001000783A PE20030179A1 (es) 1997-01-08 2001-08-07 Dispositivo de inhalacion

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2001000783A PE20030179A1 (es) 1997-01-08 2001-08-07 Dispositivo de inhalacion

Country Status (28)

Country Link
US (1) US6321747B1 (es)
EP (2) EP1378260B1 (es)
JP (1) JP2001507966A (es)
KR (1) KR20000069973A (es)
CN (2) CN1249694A (es)
AP (2) AP1165A (es)
AR (2) AR011372A1 (es)
AT (2) ATE279954T1 (es)
BR (1) BR9806864A (es)
CA (1) CA2277150A1 (es)
CO (1) CO5080756A1 (es)
CZ (1) CZ2000298A3 (es)
DE (2) DE69831517T2 (es)
EA (2) EA001291B1 (es)
GB (1) GB9700226D0 (es)
HR (1) HRP980382B1 (es)
HU (1) HU222771B1 (es)
ID (1) ID22851A (es)
IL (1) IL130687A (es)
IS (1) IS5103A (es)
NO (1) NO993348D0 (es)
NZ (1) NZ336507A (es)
PE (2) PE39599A1 (es)
PL (2) PL187815B1 (es)
TR (2) TR199901582T2 (es)
TW (1) TW404843B (es)
WO (1) WO1998030262A2 (es)
YU (1) YU32399A (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6065471A (en) * 1994-09-16 2000-05-23 Laboratoire Glaxo Wellcome Inhalation device
JPH11122624A (ja) 1997-10-16 1999-04-30 Matsushita Electric Ind Co Ltd ビデオデコーダ処理量を低減する方法および装置
WO2000074754A2 (en) * 1999-06-05 2000-12-14 Innovata Biomed Limited Delivery system
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
DE19961300A1 (de) 1999-12-18 2001-06-21 Asta Medica Ag Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator
JP2003531123A (ja) * 2000-04-13 2003-10-21 イノバータ・バイオミッド・リミテッド 医薬品
GB0015034D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
PE20020075A1 (es) 2000-06-23 2002-02-05 Norton Healthcare Ltd Dispositivo contador de dosis para inhalador de medicamento
GB0019715D0 (en) 2000-08-10 2000-09-27 Pa Consulting Services Device for delivering physiologically active agent in powdered form
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
GB0109717D0 (en) * 2001-04-20 2001-06-13 Glaxo Group Ltd Medicament dispenser
FI20011317A0 (fi) 2001-06-20 2001-06-20 Orion Corp Jauheinhalaattori
US20040244794A1 (en) * 2001-08-09 2004-12-09 Richards David Hugh Inhalation device with a pharmaceutical composition
WO2003024514A1 (en) * 2001-09-19 2003-03-27 Advent Pharmaceuticals Pty Ltd An inhaler
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US6854461B2 (en) * 2002-05-10 2005-02-15 Philip Morris Usa Inc. Aerosol generator for drug formulation and methods of generating aerosol
EP1539286B1 (de) 2002-09-16 2015-01-21 Sanofi SA Inhalator für pulverförmige, insbesondere medizinische substanzen
WO2004037807A2 (en) * 2002-10-22 2004-05-06 Glaxo Group Limited Medicinal arylethanolamine compounds
SI1556342T1 (sl) 2002-10-28 2008-08-31 Glaxo Group Ltd Fenetanolaminski derivat za zdravljenje respiratornih bolezni
GB0303396D0 (en) * 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
FR2858867B1 (fr) * 2003-08-12 2005-11-04 Valois Sa Indicateur de doses pour dispositif de distribution de produit fluide
GB0324886D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Medicinal compounds
WO2005044187A2 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
GB0329182D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
WO2005095328A1 (en) * 2004-04-02 2005-10-13 Glaxo Group Limited Chemical process and new crystalline form
EP1744800B1 (en) 2004-04-21 2016-06-22 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
NZ556335A (en) * 2005-01-11 2009-07-31 Glaxo Group Ltd Cinnamate salts of a beta-2 adrenergic agonist
WO2006086130A2 (en) * 2005-02-10 2006-08-17 Glaxo Group Limited Process for crystallizing lactose particles for use in pharmaceutical formulations
CN101155590A (zh) * 2005-02-10 2008-04-02 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
AR053346A1 (es) 2005-03-25 2007-05-02 Glaxo Group Ltd Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
TW200724142A (en) 2005-03-25 2007-07-01 Glaxo Group Ltd Novel compounds
WO2007109606A2 (en) * 2006-03-17 2007-09-27 Csp Technologies, Inc. Moisture-tight primary packaging for a dry powder inhaler
EP2033678A4 (en) 2006-06-27 2012-11-28 Otsuka Pharma Co Ltd powder inhaler
GB0625303D0 (en) * 2006-12-19 2007-01-24 Jagotec Ag Improvements in and relating to metered dose inhalers
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
EP2058025B1 (en) * 2007-11-09 2014-09-03 Hitachi Ltd. Powder medicine administering apparatus
GB0800457D0 (en) * 2008-01-11 2008-02-20 Innovata Biomed Ltd Improvements in or relating to inhalers
ES2994042T3 (en) 2009-02-26 2025-01-16 Glaxo Group Ltd Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2954888A1 (en) 2010-08-31 2015-12-16 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
AU2011298409B2 (en) 2010-08-31 2013-11-21 Glaxo Group Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
EP2874884A2 (en) * 2012-07-20 2015-05-27 Sanofi SA Metering element for an inhalation device and inhalation device comprising a metering element
AU2013352288B2 (en) 2012-11-28 2017-11-23 Intercept Pharmaceuticals, Inc. Treatment of pulmonary disease
MX2016014859A (es) 2014-05-12 2017-06-27 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas.
CA2978026A1 (en) 2015-03-11 2016-09-15 Glaxosmithkline Intellectual Property Development Limited Tslp binding proteins
RU2018101080A (ru) 2015-06-15 2019-07-15 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Регуляторы nrf2
CA2988373A1 (en) 2015-06-15 2016-12-22 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulators
HRP20240666T1 (hr) 2015-06-15 2024-08-16 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulatori
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
US10351530B2 (en) 2015-10-06 2019-07-16 Glaxosmithkline Intellectual Property Development Limited Arylcyclohexyl pyrazoles as NRF2 regulators
JP2018529745A (ja) 2015-10-06 2018-10-11 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしてのビアリールピラゾール
CA3036933A1 (en) 2016-09-20 2018-03-29 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists
US10590077B2 (en) 2016-09-20 2020-03-17 Glaxosmithkline Intellectual Property Development Limited TRPV4 antagonists
TW201825458A (zh) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產（第二）有限公司 Ｔｒｐｖ４拮抗劑
KR20190088404A (ko) 2016-12-06 2019-07-26 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
JP2020500919A (ja) 2016-12-12 2020-01-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしての３−カルボン酸ピロール
EP3551621A1 (en) 2016-12-12 2019-10-16 GlaxoSmithKline Intellectual Property Development Limited N-aryl pyrazoles as nrf2 regulators
EP3555088B1 (en) 2016-12-14 2021-11-24 GlaxoSmithKline Intellectual Property Development Limited Bisaryl amides as nrf2 regulators
JP2020502123A (ja) 2016-12-14 2020-01-23 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２アクチベーターとしてのビスアリール複素環
ES2848699T3 (es) 2016-12-14 2021-08-11 Glaxosmithkline Ip Dev Ltd Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
EP3555104B1 (en) 2016-12-15 2021-11-24 GlaxoSmithKline Intellectual Property Development Limited Nrf2 compounds
EP3555082B1 (en) 2016-12-15 2022-01-26 GlaxoSmithKline Intellectual Property Development Limited Ether linked triazoles as nrf2 regulators
WO2019116231A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
JP2021505636A (ja) 2017-12-11 2021-02-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ 急性肺傷害、急性呼吸促迫症候群および多臓器不全症候群の処置のためのｎｒｆ２アクチベーター
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
MX2020007521A (es) 2018-01-17 2022-12-05 Glaxosmithkline Ip Dev Ltd Inhibidores de pi4kiii.
WO2019224667A1 (en) 2018-05-23 2019-11-28 Glaxosmithkline Intellectual Property Development Limited Indanes as nrf2 activators
GB201908536D0 (en) 2019-06-13 2019-07-31 Glaxosmithkline Ip Dev Ltd Compounds
WO2021216547A1 (en) 2020-04-20 2021-10-28 Sorrento Therapeutics, Inc. Pulmonary administration of ace2 polypeptides
WO2022175425A1 (en) 2021-02-22 2022-08-25 Glaxosmithkline Intellectual Property Development Limited Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
US20250050039A1 (en) * 2021-12-21 2025-02-13 Chiesi Farmaceutici S.P.A. Powder inhaler

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1587657A (es) 1968-08-01 1970-03-27
US3662915A (en) * 1970-10-08 1972-05-16 Dougherty Bros Tamper proof package
US3840152A (en) * 1973-06-18 1974-10-08 None Such Enterprises Inc Sealable and resealable container
US4491238A (en) * 1983-12-12 1985-01-01 Tobolt Michael J Receptacle having a plug closure
US4762248A (en) * 1987-05-11 1988-08-09 Plastic Technologies Tamper resistant wide mouth package
US5421482A (en) * 1989-02-03 1995-06-06 Senetics, Inc. Indicator device responsive to axial force
US5718355A (en) * 1989-02-03 1998-02-17 Senetics, Inc. Indicator device responsive to axial force for use with inhaler
SE466684B (sv) * 1989-03-07 1992-03-23 Draco Ab Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
CH682227A5 (en) * 1990-11-23 1993-08-13 Edy Scheller Ag Plastics bottle closure - has closure part fixed to bottle neck with lower securing strip preventing unauthorised removal from neck
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
EP0668787B1 (en) 1992-11-12 2002-02-27 Minnesota Mining And Manufacturing Company Powder inhaler
UA27961C2 (uk) * 1992-12-18 2000-10-16 Шерінг Корпорейшн Інгалятор для порошкових ліків
US5524613A (en) * 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
CA2172537A1 (en) * 1993-09-22 1995-03-30 Gage Garby Indicator device responsive to axial force
US6065471A (en) * 1994-09-16 2000-05-23 Laboratoire Glaxo Wellcome Inhalation device

Also Published As

Publication number Publication date
HUP0000885A3 (en) 2001-02-28
HU222771B1 (hu) 2003-10-28
CN1478557A (zh) 2004-03-03
NO993348L (no) 1999-07-07
EA001291B1 (ru) 2000-12-25
EA001286B1 (ru) 2000-12-25
ATE303838T1 (de) 2005-09-15
ID22851A (id) 1999-12-09
CN1249694A (zh) 2000-04-05
HRP980382B1 (en) 2002-06-30
BR9806864A (pt) 2000-04-18
EP0954348B1 (en) 2004-10-20
AP2002002693A0 (en) 2002-12-31
DE69831517T2 (de) 2006-06-08
DE69831517D1 (de) 2005-10-13
TW404843B (en) 2000-09-11
AR011372A1 (es) 2000-08-16
TR199901582T2 (xx) 1999-09-21
NZ336507A (en) 2001-09-28
IL130687A0 (en) 2000-06-01
EP1378260B1 (en) 2005-09-07
HRP980382A2 (en) 1999-10-31
AR017446A2 (es) 2001-09-05
TR200000032T2 (tr) 2000-07-21
YU32399A (sh) 2001-05-28
PL334447A1 (en) 2000-02-28
NO993348D0 (no) 1999-07-07
AP9901596A0 (en) 1999-09-30
DE69827112T2 (de) 2005-03-24
ATE279954T1 (de) 2004-11-15
DE69827112D1 (de) 2004-11-25
AP1165A (en) 2003-06-30
EP1378260A3 (en) 2004-01-21
EA200000229A1 (ru) 2000-08-28
EP1378260A2 (en) 2004-01-07
PE20030179A1 (es) 2003-04-07
HUP0000885A2 (hu) 2000-08-28
GB9700226D0 (en) 1997-02-26
IS5103A (is) 1999-06-30
WO1998030262A2 (en) 1998-07-16
PL187248B1 (pl) 2004-06-30
JP2001507966A (ja) 2001-06-19
IL130687A (en) 2003-09-17
KR20000069973A (ko) 2000-11-25
CO5080756A1 (es) 2001-09-25
CZ2000298A3 (cs) 2000-05-17
AP1259A (en) 2004-04-23
EP0954348A2 (en) 1999-11-10
PL187815B1 (pl) 2004-10-29
WO1998030262A3 (en) 1998-10-15
US6321747B1 (en) 2001-11-27
EA199900515A1 (ru) 2000-04-24
CA2277150A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
PE39599A1 (es) Dispositivo de inhalacion
MX9300908A (es) Dispositivo dosificador.
MX9707864A (es) Inhalador de dosis medida por salmeterol.
ES2179192T3 (es) Inhibidor dosificador para albuterol.
AR009552A1 (es) Un articulo absorbente descartable que tiene un dique de contencion
GB2359987B (en) Interdental brush
NO20050368L (no) Minimalt ettergivende volumeffektivt stempel for osmotiske legemiddelleveringssystemer
AU3157793A (en) Powder inhaler using powder carriers with regular surface microfeatures
CO4940364A1 (es) Sistema de suministro de una substancia blanqueadora de dientes usando una tira de material que tiene baja rigidez en flexion
AR008957A1 (es) Inhalador de polvo para administrar polvo por inhalacion
MXPA04005969A (es) Conector medico.
CO4930332A1 (es) Sistema de suministro de una substancia para el cuidado bu- cal usando una tira de material que tiene baja rigidez en flexion
ES2155243T3 (es) Dispositivo para el maquillaje de los labios.
ES2172024T3 (es) Composicion para el tratamiento del cabello que contiene un complejo de aminoacido-metal.
BR0315583A (pt) Cobertura semi-hidrofóbica para um produto absorvente
WO1999032074A3 (en) Oral care composition
AU5816194A (en) Device for dropwise delivery of a fluid contained in a flexible vial
MX9305473A (es) Dispositivo distribuidor de medicamentos.
MX2008002465A (es) Instrumento para el cuidado oral que incluye un agente para el cuidado oral.
FR2846205B1 (fr) Dispositif de conditionnement et d'application comportant un corps contenant des particules
KR101850625B1 (ko) 구강 건강용 마우스피스
HUP0101096A2 (hu) Orrspray-készülék elasztomer szeleppel
GB2372454B (en) Medical respiratory apparatus
DE602004003425D1 (de) Küchenmaschine mit Verrriegelung und mit Werkzeug
DE50109992D1 (de) Verwendung einer Spritze für medizinische Zwecke in Verbindung mit einer Transportvorrichtung

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed